Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
Background
To date, evidence on late-onset immune-related adverse events (irAEs) with immune checkpoint inhibitors (ICIs) is limited to a small number of clinical cases. This study aimed to identify drug- and patient-related characteristics potentiall…